Literature DB >> 8905439

Toxic shock syndrome due to group C streptococci. A case report.

S Natoli1, C Fimiani, N Faglieri, L Laurenzi, A Calamaro, A M Frasca, E Arcuri.   

Abstract

BACKGROUND: Streptococcal toxic shock-like syndrome is a life-threatening illness which is on the increase. In early reports, only group A beta-hemolytic streptococcus was associated with the disease, but recent evidence indicates non-A streptococci groups are also involved. OBSERVATIONS: We describe the first reported case of streptococcal toxic shock-like syndrome caused by a group C strain in Italy. Prior to the disease, the patient, a 46-year-old man, had been in good health and had only a 3-day history of sore throat, low grade fever, vomiting, diarrhea, and myalgia before admission. Initially, diagnosis was based only on clinical evidence: shock, multiorgan failure, profound hypothermia, and no apparent signs of infection. Toxic cardiomyopathy was also present.
RESULTS: Positive throat swab and blood culture confirmed a "definite case" following established criteria. Anamnesis showed a diagnosis of monoclonal gammopathy. Antibiotic treatment was begun immediately on admission of the patient, who was discharged 20 days later in good health.
CONCLUSIONS: This case illustrates how an early diagnosis and prompt antibiotic therapy can determine a more favorable outcome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905439     DOI: 10.1007/bf02044129

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  31 in total

1.  Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.

Authors:  D R Johnson; D L Stevens; E L Kaplan
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

2.  [Case report of toxic shock-like syndrome due to group A streptococcal infection].

Authors:  Y Shimizu; A Ohymama; K Kasama; M Miyazaki; K Ooe; Y Ookochi
Journal:  Kansenshogaku Zasshi       Date:  1993-03

3.  Activity of nine antimicrobial agents against Lancefield group C and group G streptococci.

Authors:  K V Rolston; J L LeFrock; R F Schell
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

4.  A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C.

Authors:  J A Mollick; G G Miller; J M Musser; R G Cook; D Grossman; R R Rich
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  'Toxic strep syndrome'. A manifestation of group A streptococcal infection.

Authors:  T Bartter; A Dascal; K Carroll; F J Curley
Journal:  Arch Intern Med       Date:  1988-06

6.  Penicillin tolerance of human isolates of group C streptococci.

Authors:  D Portnoy; J Prentis; G K Richards
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

7.  Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study.

Authors:  A Strömberg; V Romanus; L G Burman
Journal:  J Infect Dis       Date:  1991-09       Impact factor: 5.226

8.  The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

Authors:  D L Stevens; A E Gibbons; R Bergstrom; V Winn
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

9.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

Authors:  C W Hoge; B Schwartz; D F Talkington; R F Breiman; E M MacNeill; S J Englender
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

10.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

View more
  8 in total

1.  Beta-hemolytic streptococcal erythroderma syndrome: a clinical and pathogenic analysis.

Authors:  Harmony L Tyner; Patrick M Schlievert; Larry M Baddour
Journal:  Am J Med Sci       Date:  2011-10       Impact factor: 2.378

2.  Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen.

Authors:  J K McCormick; A A Pragman; J C Stolpa; D Y Leung; P M Schlievert
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

3.  Cloning, expression, and characterization of the superantigen streptococcal pyrogenic exotoxin G from Streptococcus dysgalactiae.

Authors:  Jizi Zhao; Tomohito Hayashi; Susanna Saarinen; Anastassios C Papageorgiou; Hidehito Kato; Ken'ichi Imanishi; Teruo Kirikae; Ryo Abe; Takehiko Uchiyama; Tohru Miyoshi-Akiyama
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

4.  Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome.

Authors:  Shinnosuke Hashikawa; Yoshitsugu Iinuma; Manabu Furushita; Teruko Ohkura; Toshi Nada; Keizo Torii; Tadao Hasegawa; Michio Ohta
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

Review 5.  Fatal case of toxic shock-like syndrome due to group C streptococcus associated with superantigen exotoxin.

Authors:  Tony M Korman; Anthony Boers; Travis M Gooding; Nigel Curtis; Kumar Visvanathan
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

6.  Refractory Toxic Shock-Like Syndrome from Streptococcus dysgalactiae ssp. equisimilis and Intravenous Immunoglobulin as Salvage Therapy: A Case Series.

Authors:  Marjan Islam; Dennis Karter; Jerry Altshuler; Diana Altshuler; David Schwartz; Gianluca Torregrossa
Journal:  Case Rep Infect Dis       Date:  2016-08-15

7.  Toxic Shock Syndrome From Group C Streptococcus.

Authors:  Jocelyn McCullough; Shehnaz Wasim; Kuschner Zachary; Philip Nizza
Journal:  Cureus       Date:  2022-08-19

8.  Increased cytotoxicity and streptolysin O activity in group G streptococcal strains causing invasive tissue infections.

Authors:  Nikolai Siemens; Bård R Kittang; Bhavya Chakrakodi; Oddvar Oppegaard; Linda Johansson; Trond Bruun; Haima Mylvaganam; Mattias Svensson; Steiner Skrede; Anna Norrby-Teglund
Journal:  Sci Rep       Date:  2015-11-25       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.